Salona Global Announces Debt Reduction, Provides Update on Cost Cuts and Debt Restructuring; Appoints Mike Seckler as permanent Chief Executive Officer
July 25, 2023 07:30 ET | Salona Global Medical Device Corporation
NEW YORK, July 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“SGMD”, “Salona Global” or ‎the “Company”) (TSXV:SGMD) today announced a 15% debt reduction as part of a...
Salona Global Appoints Michael Seckler, Medical Sales & Marketing Senior Executive, as Interim CEO; Adjusts Management Team with a Focus on Cash Flow
June 14, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, Calif., June 14, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“SGMD”, “Salona Global” or the “Company”) (TSXV:SGMD) is pleased to announce the appointment of Michael...
Salona Global Announces Appointment of Lana Newishy to Board of Directors as Vice Chair and Enters into Financial Consulting Agreement
May 25, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, May 25, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) is pleased to announce the appointment of Lana Newishy...
Salona Global Closes Acquisition of Arrowhead Medical, Provides Update on Biodex Integration; Posts First Quarter Results with Positive Adjusted EBITDA, 23% Annual Revenue Growth and 27% Growth in Annual Gross Profits, Improved Quarter-over-Quarter Gross Profit from 33.1% to 38%
May 16, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) today announced it closed its acquisition of Arrowhead...
Salona Global to Host First Quarter 2023 Conference Call on May 16, 2023
May 11, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its first...
Salona Global Closes the Biodex Acquisition, Adding $26 Million in Projected Annual Revenue; Posts Audited Year-End Financial Statements with 167% Revenue Growth
April 03, 2023 07:33 ET | Salona Global Medical Device Corporation
SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) today announced it has closed the acquisition of all...
Salona Global Plans to Close the Acquisition of the Physical Medicine Business of Biodex on April 3, 2023; Engages Maxim Group LLC as Exclusive Investment Banking Advisor for US Capital Markets
March 16, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD,” or the ‎‎“Company”) (TSXV:SGMD) announced that it executed a stock purchase agreement...
Salona Global Provides Acquisitions Update, Highlights from U.S. Roadshow Presentation
February 09, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global,” “SGMD ,” or the ‎‎“Company”) (TSXV:SGMD) today provided an update to its acquisition plans and...
Salona Global Announces Third Quarter Results, Posts 211% Year-Over-Year Revenue Growth, 231% in Gross Margin Growth, Improved Gross Margin to 33%; Shifts Focus to Higher Margin Revenue Lines
January 17, 2023 07:30 ET | Salona Global Medical Device Corporation
SAN DIEGO, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) today announced highlights for the third fiscal quarter...
Salona Global to Host Third Quarter 2022 Conference Call on January 17, 2023
January 12, 2023 16:00 ET | Salona Global Medical Device Corporation
SAN DIEGO, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (TSXV:SGMD) announced that it will hold an earnings conference call (see details below) to discuss its third...